Literature DB >> 7917901

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.

B Dix1, P Robbins, S Carrello, A House, B Iacopetta.   

Abstract

Immunocytochemistry (ICC) has been used routinely to stain for p53 overexpression in a range of human tumours. The underlying assumption has been that positive staining indicates a mutation in the p53 coding sequence. Recently, however, discordancy has been observed and the accuracy of ICC as a marker of p53 gene mutation has been questioned. In this study of 109 colorectal adenocarcinomas, we compared ICC staining with p53 gene mutations detected by single-strand conformation polymorphism (SSCP) analysis. Concordancy between the two techniques was found in 69% of tumours. ICC-positive/SSCP-negative cases accounted for 20% of tumours and ICC-negative/SSCP-positive cases for the remaining 11%. These results caution against the assumption that p53 protein overexpression is always associated with a gene mutation. Epigenetic phenomena may account for a significant proportion of ICC-positive tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917901      PMCID: PMC2033416          DOI: 10.1038/bjc.1994.355

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

3.  Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.

Authors:  S M Bodner; J D Minna; S M Jensen; D D'Amico; D Carbone; T Mitsudomi; J Fedorko; D L Buchhagen; M M Nau; A F Gazdar
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

4.  Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.

Authors:  R A Lothe; T Fossli; H E Danielsen; A E Stenwig; J M Nesland; B Gallie; A L Børresen
Journal:  J Natl Cancer Inst       Date:  1992-07-15       Impact factor: 13.506

5.  Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Authors:  J Isola; T Visakorpi; K Holli; O P Kallioniemi
Journal:  J Natl Cancer Inst       Date:  1992-07-15       Impact factor: 13.506

6.  Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?

Authors:  M J O'Connell; D J Schaid; V Ganju; J Cunningham; J S Kovach; S N Thibodeau
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

Review 7.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

8.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

9.  Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Authors:  R Kikuchi-Yanoshita; M Konishi; S Ito; M Seki; K Tanaka; Y Maeda; H Iino; M Fukayama; M Koike; T Mori
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

10.  Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.

Authors:  T Starzynska; M Bromley; A Ghosh; P L Stern
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more
  24 in total

1.  p53 gene alterations and protein accumulation in colorectal cancer.

Authors:  R Bertorelle; G Esposito; C Belluco; L Bonaldi; A Del Mistro; D Nitti; M Lise; L Chieco-Bianchi
Journal:  Clin Mol Pathol       Date:  1996-04

2.  Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Authors:  Chaar Ines; Ounissi Donia; Boughriba Rahma; Azza Ben Ammar; Amara Sameh; Taher Khalfallah; Ben Hmida Abdelmajid; Mzabi Sabeh; Bouraoui Saadia
Journal:  Tumour Biol       Date:  2014-04-25

3.  The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas.

Authors:  X P Hao; I M Frayling; J G Sgouros; M Q Du; T C Willcocks; I C Talbot; I P M Tomlinson
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

4.  p53 protein accumulation and p53 gene mutation in colorectal cancer.

Authors:  A Nasierowska-Guttmejer ; L Trzeciak ; M P Nowacki ; J Ostrowski
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.

Authors:  Pooja Malhotra; Mumtaz Anwar; Neha Nanda; Rakesh Kochhar; Jai Dev Wig; Kim Vaiphei; Safrun Mahmood
Journal:  Tumour Biol       Date:  2013-03-24

7.  Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors.

Authors:  Kazuyuki Yamazumi; Toshiyuki Nakayama; Takafumi Kusaba; Chun Yang Wen; Ayumi Yoshizaki; Yuichi Yakata; Takeshi Nagayasu; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

8.  Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.

Authors:  Pang-Kuo Lo; Ji Shin Lee; Hexin Chen; David Reisman; Franklin G Berger; Saraswati Sukumar
Journal:  Exp Mol Pathol       Date:  2012-10-24       Impact factor: 3.362

Review 9.  Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature.

Authors:  B Klump; O Nehls; T Okech; C-J Hsieh; V Gaco; F S Gittinger; M Sarbia; F Borchard; A Greschniok; H H Gruenagel; R Porschen; M Gregor
Journal:  Int J Colorectal Dis       Date:  2003-06-21       Impact factor: 2.571

10.  Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers.

Authors:  Masatoshi Haseba; Shigekazu Hidaka; Takashi Tsuji; Hiroshi Yano; Hideaki Komatsu; Terumitu Sawai; Toru Yasutake; Tohru Nakagoe; Yutaka Tagawa; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.